Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

The Zacks Analyst Blog Highlights: SPDR S&P Internet ETF, Loncar Cancer Immunotherapy ETF, VanEck Vectors Steel ETF And Amplify Online Retail ETF

By Zacks Investment ResearchStock MarketsFeb 28, 2018 10:03PM ET
www.investing.com/analysis/the-zacks-analyst-blog-highlights-spdr-sp-internet-etf-loncar-cancer-immunotherapy-etf-vaneck-vectors-steel-etf-and-amplify-online-retail-etf-200295313
The Zacks Analyst Blog Highlights: SPDR S&P Internet ETF, Loncar Cancer Immunotherapy ETF, VanEck Vectors Steel ETF And Amplify Online Retail ETF
By Zacks Investment Research   |  Feb 28, 2018 10:03PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-0.47%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
RIO
+0.35%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SLX
-5.88%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
META
-1.59%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

For Immediate Release

Chicago, IL – March 1, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include SPDR S&P Internet ETF XWEB, Loncar Cancer Immunotherapy ETF CNCR, VanEck Vectors Steel ETF (AX:SLX) and Amplify Online Retail ETF IBUY.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday’s Analyst Blog:

4 Market-Beating Sector ETFs of February

The U.S. stock market was stuck in a vicious sell-off in February as inflation fears and concerns over speedy rates hike unnerved investors during the month. The initial worries were triggered by the better-than-expected jobs report that pushed the major bourses into correction territory (a decline of more than 10% from their last peak reached in late January) in early month. Then, Fed minutes and the new Fed chairperson Jerome Powell took away some sheen from the riskier assets.

However, rounds of positive economic data as well as solid long-term fundamentals led to a rebound in stocks in the back half of the month. Rising income, growing employment, optimism surrounding the new tax legislation as well as a surge in global economic growth, which continued to boost consumers’ confidence amid market turbulence, brightened up the outlook. In fact, the stocks recouped almost half of the losses seen early in the month.

That said, a few sectors have easily survived the market rout and are crushing the broad market this month. Below we have highlighted such four sectors and their best ETFs & stocks that have gained handsomely in February and could be better plays in the months ahead should the trends prevail.

Technology

After being hit by the broad market selloff in early February, the technology sector came back roaring and remained the hot spot for investors given the dual tailwinds of a rising rate scenario and the new tax repatriation policy. The emergence of cutting-edge technology such as cloud computing, big data, Internet of Things, wearables, VR headsets, drones, virtual reality, and artificial intelligence (AI) as well as strong corporate earnings are acting as the key catalysts (read: These Tech ETFs Dispel Rate Hike Fears, Hit 52-Week High).

SPDR S&P Internet ETF:This product, which targets the Internet corner of the broad tech space turned out to be a winner, climbing 4.7% this month. It tracks the S&P Internet Select Industry Index and holds 68 stocks in its basket with an equal-weight exposure of around 2%. The fund has accumulated $3.8 million in its asset base and charges 35 bps in fees from investors. It trades in a light volume of under 1,000 shares a day on average and carries a Zacks ETF Rank #3 (Hold).

Biotech

The biotech sector got a boost from its non-cyclical nature, which provides a defensive tilt toward the portfolio in a turbulent market. Additionally, a wave of mergers and acquisitions and encouraging trends including faster drug approvals, new products and Trump’s tax reform are adding to the strength (read: Biotech Crushing the Market: Best ETFs & Stocks YTD).

Loncar Cancer Immunotherapy ETF:This product tracks the Loncar Cancer Immunotherapy Index and provides exposure to a basket of companies that develop therapies to treat cancer by harnessing the body’s own immune system. It holds 31 stocks with heavy concentration on the top firm at 9.06% while other firms account for no more than 5.82% share. The ETF has amassed $54.2 million in its asset base and trades in a lower average daily volume of around 24,000 shares. The expense ratio comes in at 0.79%. The product has gained 3.8% this month and carries a Zacks ETF Rank #2 (Buy) with a High risk outlook

Steel

This sector is surging given the possible tariff talks on foreign producers of steel and aluminum in the interest of national security. Trump is looking to impose severe tariffs of 24% on steel imports and 10% for aluminum imports. Additionally, President Donald Trump’s latest statement on reviving the industry has bolstered the confidence in the growth of the steel industry, pushing the stocks and ETF higher.

VanEck Vectors Steel ETF: This fund provides pure play exposure to a small basket of 27 stocks by tracking tracks the NYSE Arca Steel Index. It is highly concentrated on the top firm – Rio Tinto (LON:RIO) – at 11% of assets while other securities hold no more than 8.9% share. American firms dominate the fund’s returns at 37.2%, followed by Brazil (19.1%), the Netherlands (13.3%) and United Kingdom (11.1%). The ETF has amassed $177.6 million in its asset base and charges 55 bps in fees from investors. It trades in moderate volume of 64,000 shares a day on average and has added 2.9% this month (read: Steel ETF Soaring: Will the Trend Continue?).

Retail

The retail sector showed upside potential thanks to a massive $1.5-trillion tax cut, which will provide consumers with extra cash that will lead to higher discretionary spending. Additionally, retailers, especially departmental stores are the biggest beneficiaries of the tax cut plan as they pay maximum taxes among the S&P 500 companies given their large domestic networks.

Amplify Online Retail ETF: This ETF offers global exposure to companies that derive 70% or more revenues from online and virtual retail by tracking the EQM Online Retail Index. The fund comprises 39 stocks that are widely diversified, with each holding no more than 5.04% of assets. It has attracted $235.4 million in its asset base and charges 65 bps in fees per year. The product trades in a moderate volume of 70,000 shares a day and has gained 1.5% in February (read: 4 ETFs at the Heart of the Market Rebound).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook (NASDAQ:FB): https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.



VANECK-STEEL (SLX): ETF Research Reports

LONCAR CANCER (CNCR): ETF Research Reports

AMPL-ONLN RETL (IBUY): ETF Research Reports

SPDR-SP INTRNT (XWEB): ETF Research Reports

Original post

Zacks Investment Research

The Zacks Analyst Blog Highlights: SPDR S&P Internet ETF, Loncar Cancer Immunotherapy ETF, VanEck Vectors Steel ETF And Amplify Online Retail ETF
 

Related Articles

The Zacks Analyst Blog Highlights: SPDR S&P Internet ETF, Loncar Cancer Immunotherapy ETF, VanEck Vectors Steel ETF And Amplify Online Retail ETF

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email